Invitae Corporation

5.37+0.8600+19.07%Vol 152.15M1Y Perf -83.76%
Aug 12th, 2022 16:00 DELAYED
BID5.25 ASK5.35
Open4.47 Previous Close4.51
Pre-Market5.26 After-Market-
 -0.11 -2.05%  - -
Target Price
7.10 
Analyst Rating
Hold 3.44
Potential %
32.22 
Finscreener Ranking
★★★     48.79
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     52.82
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     50.29
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
11.38 
Earnings Rating
Strong Buy
Market Cap1.26B 
Earnings Date
9th Aug 2022
Alpha-0.01 Standard Deviation0.24
Beta2.02 

Today's Price Range

4.416.35

52W Range

1.8332.93

5 Year PE Ratio Range

-5.20-3.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
133.48%
1 Month
82.65%
3 Months
24.31%
6 Months
-50.32%
1 Year
-83.76%
3 Years
-79.56%
5 Years
-41.57%
10 Years
-

TickerPriceChg.Chg.%
NVTA5.370.860019.07
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
20.30
-95.90
-77.00
-163.50
-93.93
RevenueValueIndustryS&P 500US Markets
364.21M
1.55
37.87
61.73
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.74-0.688.11
Q01 2022-0.77-0.78-1.30
Q04 2021-0.74-0.81-9.46
Q03 2021-0.69-0.81-17.39
Q02 2021-0.65-0.85-30.77
Q01 2021-0.60-0.63-5.00
Q04 2020-0.58-0.63-8.62
Q03 2020-0.60-0.62-3.33
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.735.19Positive
9/2022 QR-0.6513.33Positive
12/2022 FY-2.815.70Positive
12/2023 FY-2.0816.80Positive
Next Report Date-
Estimated EPS Next Report-0.74
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume152.15M
Shares Outstanding235.27K
Shares Float201.60M
Trades Count394.92K
Dollar Volume848.56M
Avg. Volume37.35M
Avg. Weekly Volume73.29M
Avg. Monthly Volume23.77M
Avg. Quarterly Volume14.99M

Invitae Corporation (NYSE: NVTA) stock closed at 5.37 per share at the end of the most recent trading day (a 19.07% change compared to the prior day closing price) with a volume of 152.15M shares and market capitalization of 1.26B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 2100 people. Invitae Corporation CEO is Sean E. George.

The one-year performance of Invitae Corporation stock is -83.76%, while year-to-date (YTD) performance is -64.83%. NVTA stock has a five-year performance of -41.57%. Its 52-week range is between 1.83 and 32.93, which gives NVTA stock a 52-week price range ratio of 11.38%

Invitae Corporation currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 2.75, a price-to-sale (PS) ratio of 2.91, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -10.71%, a ROC of -10.75% and a ROE of -17.74%. The company’s profit margin is -93.93%, its EBITDA margin is -77.00%, and its revenue ttm is $364.21 Million , which makes it $1.55 revenue per share.

Of the last four earnings reports from Invitae Corporation, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.74 for the next earnings report. Invitae Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Invitae Corporation is Hold (3.44), with a target price of $7.1, which is +32.22% compared to the current price. The earnings rating for Invitae Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Invitae Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Invitae Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 17.32, ATR14 : 1.08, CCI20 : 193.67, Chaikin Money Flow : 0.11, MACD : 0.56, Money Flow Index : 78.71, ROC : 163.24, RSI : 58.48, STOCH (14,3) : 49.37, STOCH RSI : 0.52, UO : 57.19, Williams %R : -50.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Invitae Corporation in the last 12-months were: Kenneth D. Knight (Sold 30 653 shares of value $123 573 ), Robert F. Werner (Sold 28 451 shares of value $495 238 ), Robert L. Nussbaum (Option Excercise at a value of $299 196), Robert L. Nussbaum (Sold 76 592 shares of value $1 343 427 ), Sean E. George (Option Excercise at a value of $429 000), Sean E. George (Sold 155 392 shares of value $2 097 516 ), Thomas R. Brida (Sold 70 948 shares of value $997 756 ), Yafei Wen (Sold 20 331 shares of value $86 924 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
4 (44.44 %)
4 (44.44 %)
Moderate Buy
0 (0.00 %)
1 (11.11 %)
1 (11.11 %)
Hold
7 (77.78 %)
3 (33.33 %)
4 (44.44 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
2 (22.22 %)
1 (11.11 %)
0 (0.00 %)
Summary RatingHold
3.44
Moderate Buy
2.22
Moderate Buy
2.00

Invitae Corporation

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

CEO: Sean E. George

Telephone: +1 415 374-7782

Address: 1400 16th Street, San Francisco 94103, CA, US

Number of employees: 2 100

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

TipRanks News for NVTA

Thu, 11 Aug 2022 18:43 GMT Whats behind the Invitae stock roller coaster Morgan Stanley weighs in

- TipRanks. All rights reserved.

Thu, 07 Apr 2022 02:25 GMT Analysts Are Bullish on These Healthcare Stocks: Invitae (NVTA), HCA Healthcare (HCA)

- TipRanks. All rights reserved.

Wed, 16 Feb 2022 08:46 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Invitae (NVTA) and Oscar Health (OSCR)

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 15:25 GMT Invitae (NVTA) Gets a Buy Rating from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits